Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:OASM

Oasmia Pharmaceutical AB (publ) (OASM) Stock Price, News & Analysis

About Oasmia Pharmaceutical AB (publ) Stock (NASDAQ:OASM)

Advanced Chart

Key Stats

Today's Range
$0.02
$0.02
50-Day Range
$1.30
$1.62
52-Week Range
$0.94
$5.70
Volume
N/A
Average Volume
98,414 shs
Market Capitalization
$1.50 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Oasmia Pharmaceutical AB engages in the research and development of drugs. It formulates pharmaceutical products for ovarian and breast cancer for humans and cancer for animals. The company was founded by Julian Aleksov and Bo Cederstrand on April 15, 1988 and is headquartered in Uppsala, Sweden.

Receive OASM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oasmia Pharmaceutical AB (publ) and its competitors with MarketBeat's FREE daily newsletter.

OASM Stock News Headlines

Sector-Health Care & Pharmaceuticals
Washington Is Broke—and Eyeing Your Savings Next
Washington is running out of money…And guess where they'll look next? When governments go broke, they take from the people. It's happened before, and it's happening again. The Department of Justice just admitted that cash isn't legally YOUR property.
BOEUF Bonesupport Holding AB (publ)
Lipigon Pharmaceuticals AB LPGO
Resurs Holding AB (publ) (RESURS.ST)
See More Headlines

OASM Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Oasmia Pharmaceutical AB (publ) investors own include Protalix BioTherapeutics (PLX), Amarin (AMRN), Bristol-Myers Squibb (BMY), CRISPR Therapeutics (CRSP), Supernus Pharmaceuticals (SUPN), VBI Vaccines (VBIV) and Verastem (VSTM).

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:OASM
Fax
N/A
Employees
57
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-18,950,000.00
Net Margins
-8,633.64%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$220,000.00
Price / Cash Flow
N/A
Book Value
$0.63 per share
Price / Book
0.03

Miscellaneous

Free Float
N/A
Market Cap
$1.50 million
Optionable
Not Optionable
Beta
0.96
10 Stocks Set to Soar in Spring 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:OASM) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners